What Granules Pharmaceuticals Inc. pays on H-1B filings

Granules Pharmaceuticals Inc. filed 81 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.

FY2026 so far · 39 LCAsFY2025 · 42 LCAs

Stated wages by title

TitleLCAsYearTypical rangeMedian
Biochemist12FY2025$67,038 to $80,000$75,000
Pharmaceutical Manufacturing Quality Control Analyst12FY2025$54,080 to $54,080$54,080
Scientist8FY2026 so far$83,928 to $99,375$84,464
QA Associate5FY2026 so far$60,580 to $75,000$63,003
Associate Director3FY2026 so far$155,688 to $164,133$164,133

Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.

Filings by fiscal year

Fiscal yearCertified LCAs
FY2026 (October to June)39
FY202542

By prevailing-wage level

LevelLCAsMedian stated wage
Level I (entry)48$63,347
Level II (qualified)21$95,000
Level III (experienced)5$104,166
Level IV (fully competent)7$185,000

DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.

Top worksites

WorksiteLCAsMedian stated wage
Chantilly, VA69$67,038
Manassas, VA1$120,000

Looking at Granules Pharmaceuticals Inc.?

Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.